Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients.

Tsai EW, Rianthavorn P, Gjertson DW, Wallace WD, Reed EF, Ettenger RB.

Transplantation. 2006 Dec 27;82(12):1769-73.

PMID:
17198274
2.

New treatments for acute humoral rejection of kidney allografts.

Venetz JP, Pascual M.

Expert Opin Investig Drugs. 2007 May;16(5):625-33. Review.

PMID:
17461736
3.

Current approaches to treatment of antibody-mediated rejection.

Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M.

Pediatr Transplant. 2005 Jun;9(3):408-15. Review.

PMID:
15910400
4.

The yin and yang of B cells in graft rejection and tolerance.

Zarkhin V, Chalasani G, Sarwal MM.

Transplant Rev (Orlando). 2010 Apr;24(2):67-78. doi: 10.1016/j.trre.2010.01.004. Epub 2010 Feb 10. Review.

PMID:
20149626
5.

Insights into subclinical rejection.

Rush D; Winnipeg Transplant Group.

Transplant Proc. 2004 Mar;36(2 Suppl):71S-73S. Review.

PMID:
15041310
6.

The emerging role of rituximab in organ transplantation.

Becker YT, Samaniego-Picota M, Sollinger HW.

Transpl Int. 2006 Aug;19(8):621-8. Review.

7.

Antibodies in the prevention of renal allograft rejection.

Pankhurst T, Adu D.

Expert Opin Biol Ther. 2004 Feb;4(2):243-52. Review.

PMID:
14998781
8.

B-cell activity of polyclonal antithymocyte globulins.

Zand MS.

Transplantation. 2006 Dec 15;82(11):1387-95. Review.

PMID:
17164703
9.

[Immunopathology of acute rejection].

Cohen AH.

G Ital Nefrol. 2005 Nov-Dec;22 Suppl 33:S71-5. Review. Italian.

PMID:
16419010
10.

The evolving role of chemokines and their receptors in acute allograft rejection.

Inston NG, Cockwell P.

Nephrol Dial Transplant. 2002 Aug;17(8):1374-9. Review. No abstract available.

PMID:
12147781
11.

Effects of CD20+ B-cell infiltration into allografts on kidney transplantation outcomes: a systematic review and meta-analysis.

Lu Y, Li B, Shen Q, Wang R, Chen Z, Jiang H, Chen J.

Oncotarget. 2017 Jun 6;8(23):37935-37941. doi: 10.18632/oncotarget.16229. Review.

12.

B cells in renal transplantation: pathological aspects and therapeutic interventions.

Barnett N, Dorling A, Mamode N.

Nephrol Dial Transplant. 2011 Mar;26(3):767-74. doi: 10.1093/ndt/gfq716. Epub 2010 Dec 7. Review.

PMID:
21139038
13.

Basic mechanisms of humoral rejection.

Cascalho M, Platt JL.

Pediatr Transplant. 2005 Feb;9(1):9-16. Review.

PMID:
15667605
14.

The role of macrophages in allograft rejection.

Wyburn KR, Jose MD, Wu H, Atkins RC, Chadban SJ.

Transplantation. 2005 Dec 27;80(12):1641-7. Review.

PMID:
16378052
15.

Immunodeficiency in chronic renal insufficiency.

Traeger J, Touraine JL, Navarro J, Freyria J, Contreras P.

Proc Eur Dial Transplant Assoc. 1980;17:375-82. Review. No abstract available.

PMID:
7017678
16.

Cellular transplantation and gene therapy.

Ricordi C, Ildstad ST, Starzl TE.

Clin Transplant. 1993 Feb;7(1 part 2):75-81. Review. No abstract available.

17.

The cellular and molecular basis of allograft rejection: what do we know?

Strom TB.

Transplant Proc. 1988 Apr;20(2):143-6. Review. No abstract available.

PMID:
3284031
18.

Human renal allografts. The role of vascular injury in early graft failure.

Busch GJ, Reynolds ES, Galvanek EG, Braun WE, Dammin GJ.

Medicine (Baltimore). 1971 Jan;50(1):29-83. Review. No abstract available.

PMID:
5101107
19.

Graft compatibility and incompatibility in higher plants.

Moore R.

Dev Comp Immunol. 1981 Summer;5(3):377-89. Review. No abstract available.

PMID:
7024007

Supplemental Content

Support Center